Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06773182

Assessing Interventions of Diet in IBD

Understanding Patient's Barriers and Perceived Benefits Through Adherence to Nutritional Interventions in IBD: a Preliminary Study.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.

Detailed description

This study aims to explore the impact of specific dietary interventions on individuals living with inflammatory bowel disease (IBD). By examining dietary patterns such as intermittent fasting, the Mediterranean diet, and the Low FODMAP diet, we seek to identify barriers to adherence and facilitators that make these eating plans sustainable. Additionally, we aim to evaluate the perceived benefits of these diets in managing IBD symptoms and their influence on overall quality of life. The findings will provide valuable insights to develop patient-centered nutritional strategies that enhance adherence and therapeutic outcomes in IBD care.

Conditions

Interventions

TypeNameDescription
OTHERIntermittent Fasting InterventionA 14:10 intermittent fasting regimen, where participants fast for 14 hours and consume all meals within a 10-hour eating window daily.
OTHERMediterranean Diet InterventionA diet emphasizing whole grains, fruits, vegetables, olive oil, lean proteins, and minimizing processed foods.
OTHERLow FODMAP Diet InterventionA diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms.

Timeline

Start date
2025-04-01
Primary completion
2026-04-01
Completion
2027-01-01
First posted
2025-01-14
Last updated
2025-06-26

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06773182. Inclusion in this directory is not an endorsement.